Events

Retiro De Equipo O Alerta De Seguridad para Thoratec Heartmate II Left Ventricular Assist System (HM II LVAS) System Controllers

Según Ministry of Health Malaysia, este evento ( retiro de equipo o alerta de seguridad ) involucró a un dispositivo médico en Malaysia que fue producido por Thoratec Corporation.

¿Qué es esto?

Las alertas proporcionan información importante y recomendaciones sobre los productos. Aunque se haya emitido una alerta, esto no significa necesariamente que el producto se considera peligroso. Las alertas de seguridad, dirigidas a trabajadores de la salud y a usuarios, pueden incluir retiro de equipos. Pueden ser escritas por los fabricantes, pero también por funcionarios del área de salud.

Más información acerca de la data acá
  • Tipo de evento
    Recall / Safety alert
  • País del evento
    Malaysia
  • Fuente del evento
    MHM
  • URL de la fuente del evento
    https://portal.mda.gov.my/
  • Notas / Alertas
    Malaysian data is current through October 2018. All of the data comes from the Ministry of Health Malaysia, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Malaysia.
  • Notas adicionales en la data
    ALERT: Thoratec Heartmate II Left Ventricular Assist System (HM II LVAS) System Controllers1. Letter from MDB 2. Letter from THORATEC

Device

Thoratec Heartmate II Left Ventricular Assist System (HM II LVAS) System Controllers

Manufacturer

Thoratec Corporation
  • Empresa matriz del fabricante (2017)
    Abbott Laboratories
  • Comentario del fabricante
    “We are in constant communication with regulatory agencies and competent authorities worldwide which allows us to implement global recalls or in-country communication quickly and effectively,” Abbott, which now owns St. Jude Medical told ICIJ in a statement. In addition to sending global notices to physicians worldwide, we also make sure that product advisories are available online and classification of product recalls and product advisories are determined by global regulatory bodies which can impact the timing in any given country. MD companies follow varying regulations in different countries. In come countries software is not regulated so a recall in one country related to software would not be classified as a recall or field action in another. In addition, review cycles within the regulatory process can be different in each country which can impact communication and recall timing.
  • Source
    MHM